About Strata Skin Sciences (NASDAQ:SSKN)
STRATA Skin Sciences, Inc., formerly MELA Sciences, Inc., is a medical technology company. The Company is engaged in developing and commercializing products for the diagnosis and treatment of dermatological disorders. The Company has three segments: Dermatology Recurring Procedures, Dermatology Procedures Equipment and Dermatology Imaging. The XTRAC and VTRAC products are the devices used for the treatment of psoriasis, vitiligo and other skin disorders. The XTRAC system delivers targeted ultraviolet light to affected areas of skin, leading to psoriasis clearing and vitiligo repigmentation, following a series of treatments. The Company's technology includes XTRAC Excimer Laser, VTRAC Lamp and MelaFind. MelaFind is a non-invasive, point-of-care instrument to aid dermatologists in their decision to biopsy suspicious pigmented lesions, such as melanoma. The Company has approximately two distribution channels for phototherapy treatment equipment.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Medical Instruments & Supplies
- Sub-Industry: N/A
- Symbol: NASDAQ:SSKN
- CUSIP: N/A
- Web: www.strataskinsciences.com
- Market Cap: $3.64 million
- Outstanding Shares: 2,477,000
- 50 Day Moving Avg: $1.75
- 200 Day Moving Avg: $2.20
- 52 Week Range: $0.43 - $5.40
Sales & Book Value:
- Trailing P/E Ratio: N/A
- Foreward P/E Ratio: -1.91
- P/E Growth: -0.02
- Annual Revenue: $32.37 million
- Price / Sales: 0.11
- Book Value: $4.69 per share
- Price / Book: 0.31
- EBITDA: $5.87 million
- Net Margins: -18.00%
- Return on Equity: -41.58%
- Return on Assets: -13.22%
- Debt-to-Equity Ratio: 1.85%
- Current Ratio: 1.34%
- Quick Ratio: 0.93%
- Average Volume: 189,288 shs.
- Beta: 0.46
- Short Ratio: 2.51
Frequently Asked Questions for Strata Skin Sciences (NASDAQ:SSKN)
What is Strata Skin Sciences' stock symbol?
Strata Skin Sciences trades on the NASDAQ under the ticker symbol "SSKN."
When did Strata Skin Sciences' stock split? How did Strata Skin Sciences' stock split work?
Strata Skin Sciences's stock reverse split on Thursday, July 10th 2014. The 1-10 reverse split was announced on Thursday, July 3rd 2014. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, July 9th 2014. An investor that had 100 shares of Strata Skin Sciences stock prior to the reverse split would have 10 shares after the split.
How were Strata Skin Sciences' earnings last quarter?
Strata Skin Sciences, Inc. (NASDAQ:SSKN) announced its earnings results on Thursday, August, 10th. The company reported ($0.52) earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of ($0.71) by $0.19. The company earned $8.70 million during the quarter, compared to analyst estimates of $7.98 million. Strata Skin Sciences had a negative net margin of 18.00% and a negative return on equity of 41.58%. View Strata Skin Sciences' Earnings History.
When will Strata Skin Sciences make its next earnings announcement?
Where is Strata Skin Sciences' stock going? Where will Strata Skin Sciences' stock price be in 2017?
2 brokerages have issued 1-year price targets for Strata Skin Sciences' stock. Their predictions range from $12.00 to $12.00. On average, they expect Strata Skin Sciences' stock price to reach $12.00 in the next year. View Analyst Ratings for Strata Skin Sciences.
Who are some of Strata Skin Sciences' key competitors?
Some companies that are related to Strata Skin Sciences include Bio Blast Pharma (ORPN), Senesco Technologies (SVON), OncoGenex Pharmaceuticals (ACHV), NeuroMetrix (NURO), Rosetta Genomics (ROSG), Windtree Therapeutics (WINT), Affymax (AFFY), Tetralogic Pharmaceuticals Corp (TLOG), Adeptus Health (ADPT), Caladrius Biosciences (CLBS), DNIB Unwind (BIND), Echo Therapeutics (ECTE), Epirus Biopharmaceuticals (EPRS), Luxottica Group SpA (LUX), Mast Therapeutics (MSTX), Parnell Pharmaceuticals Holdings Ltd (PARN), Secure Point Technologies (IMSC) and Sunshine Heart (SSH).
How do I buy Strata Skin Sciences stock?
Shares of Strata Skin Sciences can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Strata Skin Sciences' stock price today?
MarketBeat Community Rating for Strata Skin Sciences (NASDAQ SSKN)MarketBeat's community ratings are surveys of what our community members think about Strata Skin Sciences and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
One share of Strata Skin Sciences stock can currently be purchased for approximately $1.47.
Consensus Ratings for Strata Skin Sciences (NASDAQ:SSKN) (How are Consensus Ratings Calculated?)
MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.
MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
|Ratings Breakdown: ||2 Buy Ratings|
|Consensus Rating:||Buy (Score: 3.00)|
|Consensus Price Target: ||$12.00 (716.33% upside)|Consensus Price Target History for Strata Skin Sciences (NASDAQ:SSKN)
Analysts' Ratings History for Strata Skin Sciences (NASDAQ:SSKN)
(Data available from 10/22/2015 forward)
|Date||Firm||Action||Rating||Price Target||Impact on Share Price||Details|
|10/18/2017||HC Wainwright||Set Price Target||Buy||$12.00||N/A|
|5/16/2017||Rodman & Renshaw||Boost Price Target||Buy -> Buy||$1.50 -> $12.00||High|
Earnings History for Strata Skin Sciences (NASDAQ:SSKN)Earnings History by Quarter for Strata Skin Sciences (NASDAQ SSKN)
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|8/10/2017||Q2 2017||($0.71)||($0.52)||$7.98 million||$8.70 million||View||N/A|
|5/12/2016||Q1||($0.18)||($0.26)||$9.15 million||$7.62 million||View||Listen|
|3/10/2016||Q4||($0.22)||($0.06)||$8.50 million||$9.48 million||View||Listen|
|11/12/2015||Q315||($0.11)||($1.29)||$8.10 million||$8.30 million||View||Listen|
|8/13/2015||Q215||($0.31)||($0.97)||$0.20 million||$0.61 million||View||Listen|
|5/14/2015||Q1||($0.37)||($1.12)||$0.25 million||$0.08 million||View||N/A|
|3/30/2015||($0.59)||($1.14)||$0.28 million||$0.37 million||View||N/A|
|3/17/2014||Q4||($0.09)||$122.00 million||$140.00 million||View||Listen|
|8/7/2013||Q2 2013||($0.17)||($0.17)||$0.25 million||$0.14 million||View||Listen|
Earnings Estimates for Strata Skin Sciences (NASDAQ:SSKN)
Current Year EPS Consensus Estimate: $-3.14 EPS
Next Year EPS Consensus Estimate: $-0.77 EPS
Dividend History for Strata Skin Sciences (NASDAQ:SSKN)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for Strata Skin Sciences (NASDAQ:SSKN)
Insider Ownership Percentage: 12.92%Insider Trades by Quarter for Strata Skin Sciences (NASDAQ:SSKN)
Institutional Ownership Percentage: 24.06%
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|11/28/2016||Frank J Mccaney||CEO||Buy||20,000||$0.51||$10,200.00|| |
|3/11/2016||Healthcare Master Fun Broadfin||Major Shareholder||Sell||266,000||$1.31||$348,460.00|| |
|5/22/2014||Anthony J Dimun||Director||Buy||87,500||$0.38||$33,250.00|| |
|2/5/2014||David Stone||Director||Buy||13,514||$0.74||$10,000.36|| |
|2/5/2014||Robert Coradini||Chairman||Buy||67,567||$0.74||$49,999.58|| |
|2/5/2014||Rosemary Crane||CEO||Buy||67,570||$0.74||$50,001.80|| |
|6/28/2013||Robert Coradini||CEO||Buy||15,000||$0.99||$14,850.00|| |
|6/27/2013||Anne M Egger||Director||Buy||11,000||$0.90||$9,900.00|| |
|6/27/2013||Robert Coradini||CEO||Buy||15,000||$0.87||$13,050.00|| |
|6/26/2013||Luann Via||Director||Buy||15,000||$0.79||$11,850.00|| |
|6/25/2013||Richard I Steinhart||CFO||Buy||3,000||$0.81||$2,430.00|| |
|6/24/2013||Kathryn B Swintek||Director||Buy||17,000||$0.73||$12,410.00|| |
|6/24/2013||Robert Coradini||CEO||Buy||50,000||$0.72||$36,000.00|| |
|6/21/2013||Kathryn B Swintek||Director||Buy||3,000||$0.79||$2,370.00|| |
|6/20/2013||Mindy C Meads||Director||Buy||5,070||$0.79||$4,005.30|| |
|6/19/2013||David K Stone||Director||Buy||10,000||$0.82||$8,200.00|| |
|5/3/2013||Joseph V Gulfo||CEO||Buy||25,000||$1.08||$27,000.00|| |
|3/13/2013||Joseph V Gulfo||CEO||Buy||20,000||$1.15||$23,000.00|| |
|11/12/2012||Joseph V Gulfo||CEO||Buy||10,000||$2.68||$26,800.00|| |
Headline Trends for Strata Skin Sciences (NASDAQ:SSKN)
Latest Headlines for Strata Skin Sciences (NASDAQ:SSKN)
Loading headlines, please wait.
Strata Skin Sciences (SSKN) Chart for Sunday, October, 22, 2017